- Report
- July 2024
- 133 Pages
Spain
From €2662EUR$2,999USD£2,300GBP
- Report
- May 2024
- 133 Pages
Global
From €5768EUR$6,499USD£4,983GBP
- Report
- May 2024
- 137 Pages
Global
From €5768EUR$6,499USD£4,983GBP
- Report
- May 2024
- 134 Pages
Global
From €5768EUR$6,499USD£4,983GBP
- Report
- May 2024
- 129 Pages
Global
From €5768EUR$6,499USD£4,983GBP
- Report
- May 2024
- 139 Pages
Global
From €5768EUR$6,499USD£4,983GBP
- Report
- May 2024
- 129 Pages
Global
From €5768EUR$6,499USD£4,983GBP
- Report
- May 2024
- 128 Pages
Global
From €5768EUR$6,499USD£4,983GBP
- Report
- May 2024
- 130 Pages
Global
From €5768EUR$6,499USD£4,983GBP
- Report
- May 2024
- 140 Pages
Global
From €5768EUR$6,499USD£4,983GBP
- Report
- May 2024
- 139 Pages
Global
From €5768EUR$6,499USD£4,983GBP
- Report
- May 2024
- 128 Pages
Global
From €5768EUR$6,499USD£4,983GBP
- Report
- May 2024
- 134 Pages
Global
From €5768EUR$6,499USD£4,983GBP
- Report
- May 2024
- 140 Pages
Global
From €5768EUR$6,499USD£4,983GBP
- Report
- May 2023
- 132 Pages
India
From €2662EUR$2,999USD£2,300GBP
- Report
- April 2021
China
From €2308EUR$2,600USD£1,994GBP
- Report
- November 2018
- 30 Pages
China
From €1953EUR$2,200USD£1,687GBP
From €3106EUR$3,500USD£2,684GBP
- Report
- February 2025
- 85 Pages
India
From €3106EUR$3,500USD£2,684GBP
- Report
- December 2024
- 85 Pages
India
From €3106EUR$3,500USD£2,684GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more